Mural Oncology plc (NASDAQ: MURA) announced that its shareholders have approved the proposed acquisition by XRA 5 Corp., a wholly ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE